Truist Financial
CNMD icon

Truist Financial’s CONMED CNMD Stock Holding History

Truist Financial’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,493
Closed -$602K – 2637
2023
Q4 		$602K Sell
5,493
-848
-13% -$87.7K ﹤0.01% 1875
2023
Q3 		$640K Buy
6,341
+265
+4% +$30.4K ﹤0.01% 1785
2023
Q2 		$826K Sell
6,076
-84
-1% -$10.3K ﹤0.01% 1674
2023
Q1 		$640K Buy
6,160
+1,413
+30% +$137K ﹤0.01% 1825
2022
Q4 		$421K Sell
4,747
-328
-6% -$27.2K ﹤0.01% 2078
2022
Q3 		$407K Buy
5,075
+646
+15% +$60.9K ﹤0.01% 1930
2022
Q2 		$424K Buy
4,429
+1,007
+29% +$121K ﹤0.01% 2012
2022
Q1 		$508K Buy
3,422
+1,666
+95% +$233K ﹤0.01% 1997
2021
Q4 		$249K Buy
+1,756
New +$249K ﹤0.01% 2478

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Truist Financial's CNMD Position: Q1 2024 in Review

Truist Financial sold out of CONMED (CNMD) in Q1 2024, closing a stake of 5,493 shares — an estimated $602K sold.

Truist Financial first reported a position in CNMD in Q4 2021 and held it in 9 quarters. The position peaked at $826K in Q2 2023. 298 funds tracked by Wall St. Rank hold CNMD as of Q1 2024.

  • Truist Financial reported no remaining CONMED position as of Q1 2024 after selling out during the quarter.
  • Truist Financial sold 5,493 CONMED shares in Q1 2024, an estimated $602K.
  • Truist Financial first reported a position in CONMED in Q4 2021 and held it in 9 quarters.
  • Truist Financial's CONMED position peaked at $826K in Q2 2023.
  • 298 funds tracked by Wall St. Rank held CONMED as of Q1 2024.

Based on Truist Financial's 13F filing for Q1 2024, filed 13 May 2024.